MEET OUR FOUNDER

Dr. Carlton D. Donald

FOUNDER & PRESIDENT/CEO · CHAIRMAN OF THE BOARD

Dr. Carlton D. Donald founded Phigenix in 2007. He is a molecular biologist and clinical research scientist with over 25 years of experience in cancer research. To date, Dr. Donald has approximately 100 patents, pending patents, and applications in the area of oncology, and has authored a number of ground-breaking articles on cancer initiation and progression as well as tumor immunity. Dr. Donald continues to provide his scientific expertise in the research and development of Phigenix's diagnostics and therapeutics. He also serves as the Chairman of the Board of Directors.